4771 Stock Overview
Engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
Vizionfocus Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$236.50 |
52 Week High | NT$384.50 |
52 Week Low | NT$201.00 |
Beta | 1.13 |
11 Month Change | -8.51% |
3 Month Change | -23.34% |
1 Year Change | 12.35% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 60.88% |
Recent News & Updates
Shareholder Returns
4771 | TW Medical Equipment | TW Market | |
---|---|---|---|
7D | 1.9% | 1.8% | 4.2% |
1Y | 12.4% | 20.9% | 35.3% |
Return vs Industry: 4771 underperformed the TW Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: 4771 underperformed the TW Market which returned 35.3% over the past year.
Price Volatility
4771 volatility | |
---|---|
4771 Average Weekly Movement | 5.4% |
Medical Equipment Industry Average Movement | 4.8% |
Market Average Movement | 5.7% |
10% most volatile stocks in TW Market | 9.4% |
10% least volatile stocks in TW Market | 3.0% |
Stable Share Price: 4771's share price has been volatile over the past 3 months.
Volatility Over Time: 4771's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | An Shi | www.vizionfocus.com |
Vizionfocus Inc. engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, development, production, and wholesale of contact lenses.
Vizionfocus Inc. Fundamentals Summary
4771 fundamental statistics | |
---|---|
Market cap | NT$13.29b |
Earnings (TTM) | NT$711.00m |
Revenue (TTM) | NT$3.01b |
19.1x
P/E Ratio4.5x
P/S RatioIs 4771 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4771 income statement (TTM) | |
---|---|
Revenue | NT$3.01b |
Cost of Revenue | NT$1.77b |
Gross Profit | NT$1.23b |
Other Expenses | NT$522.41m |
Earnings | NT$711.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 12.36 |
Gross Margin | 41.01% |
Net Profit Margin | 23.64% |
Debt/Equity Ratio | 31.2% |
How did 4771 perform over the long term?
See historical performance and comparison